Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1

被引：6
|
作者：
Thomas, S. [1 ,2 ]
Laino, A. [1 ,2 ]
Sturm, R. [1 ]
Nufer, K. [1 ]
Lambie, D. [2 ,3 ]
Shepherd, B. [2 ]
Atkinson, V. [4 ]
Adams, L. [1 ]
Soyer, H. P. [1 ,2 ]
Schaider, H. [1 ]
机构：
[1] Univ Queensland, Translat Res Inst, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia
[2] Princess Alexandra Hosp, Dept Dermatol, Brisbane, Qld, Australia
[3] IQ Pathol, Brisbane, Qld, Australia
[4] Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 05期
关键词：
MALIGNANT-MELANOMA; MANAGEMENT; COHORT;
D O I：
10.1111/jdv.14678
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E176 / E177
页数：2
相关论文
共 50 条
  • [1] Second primary melanoma in advanced melanoma patients treated with anti-PD-1 monoclonal antibodies.
    Funck-Brentano, Elisa
    Charvet, Estelle
    Chaplain, Louise
    Gantzer, Amelie
    Kassem, Oula
    Longvert, Christine
    Blom, Astrid
    Dupin, Nicolas
    Aractingi, Selim
    Hamon, Maxime
    Zimmermann, Ute
    Emile, Jean-Francois
    Sohier, Pierre
    Kramkimel, Nora
    Saiag, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Lichenoid Dermatitis in Three Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
    Joseph, Richard W.
    Cappel, Mark
    Goedjen, Brent
    Gordon, Matthew
    Kirsch, Brandon
    Gilstrap, Cheryl
    Bagaria, Sanjay
    Jambusaria-Pahlajani, Anokhi
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) : 18 - 22
  • [3] Resistance patterns to anti-PD-1 therapy in metastatic melanoma
    Ozgun, Alpaslan
    Sondak, Vernon K.
    Markowitz, Joseph
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (06)
  • [4] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [5] Proteomic biomarker analysis of metastatic melanoma patients treated with anti-PD-1 checkpoint blockade
    Ascierto, Paolo Antonio
    Capone, Mariaelena
    Grimaldi, Antonio Maria
    Mallardo, Domenico
    Simeone, Ester
    Roder, Heinrich
    Meyer, Krista
    Asmellash, Senait
    Oliveira, Carlos
    Roder, Joanna
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [6] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma
    Li, Mengqian
    LANCET ONCOLOGY, 2021, 22 (08): : E342 - E342
  • [7] Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?
    Bender, Carolin
    Enk, Alexander
    Gutzmer, Ralf
    Hassel, Jessica C.
    CANCER MEDICINE, 2017, 6 (07): : 1581 - 1586
  • [8] Anti-PD-1 approaches—important steps forward in metastatic melanoma
    Mina Razzak
    Nature Reviews Clinical Oncology, 2013, 10 (7) : 365 - 365
  • [9] Antiepidermis autoantibodies induced by anti-PD-1 therapy in metastatic melanoma
    Brunet-Possenti, Florence
    Mignot, Sabine
    Deschamps, Lydia
    Descamps, Vincent
    MELANOMA RESEARCH, 2016, 26 (05) : 540 - 543
  • [10] The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma
    Ladwa, Rahul
    Atkinson, Victoria
    MELANOMA RESEARCH, 2017, 27 (02) : 168 - 170
12345